Evidence map›Paper›PMID 35316841›Full record

ArticlePediatric surgery international2022

Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction.

Massimo Garriboli, Koichi Deguchi, Giorgia Totonelli, Fanourios Georgiades, Luca Urbani, Marco Ghionzoli, Alan J Burns, Neil J Sebire, Mark Turmaine, Simon Eaton and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Pediatric surgery international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. [Application and progress of bio-derived materials in bladder regeneration and repair].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Massimo GarriboliStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Koichi DeguchiStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Giorgia TotonelliStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Fanourios GeorgiadesStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Luca UrbaniStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Marco GhionzoliStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Alan J BurnsNeural Development Unit, Institute of Child Health, University College London, 30 Guilford Street, London, UK.
Neil J SebireDepartment of Histopathology, Institute of Child Health and Great Ormond Street Hospital, University College London, London, UK.
Mark TurmaineDivision of Bioscience, University College London, London, UK.
Simon EatonStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Paolo De CoppiStem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. p.decoppi@ucl.ac.uk.
University College London · GBGreat Ormond Street Hospital · GB

Funding

Medical Research Council MR/L013347/1Medical Research Council MR/N028414/1
6 · The paper itself

Abstract

purposeEnterocystoplasty is adopted for patients requiring bladder augmentation, but significant long-term complications highlight need for alternatives. We established a protocol for creating a natural-derived bladder extracellular matrix (BEM) for developing tissue-engineered bladder, and investigated its structural and functional characteristics.

methodsPorcine bladders were de-cellularised with a dynamic detergent-enzymatic treatment using peristaltic infusion. Samples and fresh controls were evaluated using histological staining, ultrastructure (electron microscopy), collagen, glycosaminoglycans and DNA quantification and biomechanical testing. Compliance and angiogenic properties (Chicken chorioallantoic membrane [CAM] assay) were evaluated. T test compared stiffness and glycosaminoglycans, collagen and DNA quantity. p value of < 0.05 was regarded as significant.

resultsHistological evaluation demonstrated absence of cells with preservation of tissue matrix architecture (collagen and elastin). DNA was 0.01 μg/mg, significantly reduced compared to fresh tissue 0.13 μg/mg (p < 0.01). BEM had increased tensile strength (0.259 ± 0.022 vs 0.116 ± 0.006, respectively, p < 0.0001) and stiffness (0.00075 ± 0.00016 vs 0.00726 ± 0.00216, p = 0.011). CAM assay showed significantly increased number of convergent allantoic vessels after 6 days compared to day 1 (p < 0.01). Urodynamic studies showed that BEM maintains or increases capacity and compliance.

conclusionDynamic detergent-enzymatic treatment produces a BEM which retains structural characteristics, increases strength and stiffness and is more compliant than native tissue. Furthermore, BEM shows angiogenic potential. These data suggest the use of BEM for development of tissue-engineered bladder for patients requiring bladder augmentation.

Indexed as

Tissue EngineeringUrinary BladderAnimalsCollagenExtracellular MatrixHumansSwineUrologic Surgical ProceduresCollagenBladder augmentationDe-cellularisationExtracellular matrixTissue engineering

Identifiers

PMID35316841
PMCPMC8983501
OpenAlexW4220959596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.